GTR 107880961
Tenders Are Invited For A Laronidase (Genetical Recombination) (2.9Mg 5Ml×1Vial/Case) 2,025 Cases, Ravulizumab (Genetical Recombination) (300Mg 3Ml×1VialCase) 242 Cases, Ravulizumab (Genetical Recombination) (1100Mg 11Ml×1VialCase) 68 Cases, Inebilizumab (Genetical Recombination) (100Mg 10Ml×3VialCase) 6 ...
ICB — International Competitive Bid
Closed
Asia
Tender Information
GTR Reference
107880961
Tendering Authority
Subscribe to view
Tender No
379792
Financer Name
Self-Funded
Work Title
Tenders Are Invited For A Laronidase (Genetical Recombination) (2.9Mg 5Ml×1Vial/Case) 2,025 Cases, Ravulizumab (Genetical Recombination) (300Mg 3Ml×1VialCase) 242 Cases, Ravulizumab (Genetical Recombination) (1100Mg 11Ml×1VialCase) 68 Cases, Inebilizumab (Genetical Recombination) (100Mg 10Ml×3VialCase) 6 ...
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Asia-Pacific Economic Cooperation, APEC,G20,APAC (Asia Pacific)
Last Date of Bid Submission
17-03-2026
Closed
Work Detail
A Laronidase (Genetical Recombination) (2.9Mg 5Ml×1Vial/Case) 2,025 Cases, Ravulizumab (Genetical Recombination) (300Mg 3Ml×1VialCase) 242 Cases, Ravulizumab (Genetical Recombination) (1100Mg 11Ml×1VialCase) 68 Cases, Inebilizumab (Genetical Recombination) (100Mg 10Ml×3VialCase) 6 ...
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
8eb3c3b9-2d33-4034-87ed-b6947d83e9d8.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.